Extraskeletal Ewing sarcoma in children, adolescents, and young adults. An analysis of three prospective studies of the Cooperative Weichteilsarkomstudiengruppe (CWS)

We have analyzed the outcome of patients with localized extraskeletal Ewing sarcoma (EES) treated in three consecutive Cooperative Weichteilsarkomstudiengruppe (CWS) soft tissue sarcoma (STS) studies: CWS‐91, CWS‐96, and CWS‐2002P.

[1]  H. Gelderblom,et al.  Comparison of two chemotherapy regimens in Ewing sarcoma (ES): Overall and subgroup results of the Euro Ewing 2012 randomized trial (EE2012). , 2020 .

[2]  A. Ferrari,et al.  Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial. , 2019, The Lancet. Oncology.

[3]  Kelly M. Bailey,et al.  Microenvironmental Factors Drive Tenascin C and Src Cooperation to Promote Invadopodia Formation in Ewing Sarcoma , 2019, Neoplasia.

[4]  S. Bielack,et al.  Desmoplastic small round cell tumors: Multimodality treatment and new risk factors , 2019, Cancer medicine.

[5]  Andrew D. Lynch,et al.  Extraskeletal versus Skeletal Ewing Sarcoma in the adult population: Controversies in care. , 2018, Surgical oncology.

[6]  E. Koscielniak,et al.  Fifty years of rhabdomyosarcoma studies on both sides of the pond and lessons learned. , 2018, Cancer treatment reviews.

[7]  R. Marks,et al.  Extraskeletal Osteosarcoma: Outcomes and the Role of Chemotherapy , 2017, American journal of clinical oncology.

[8]  D. Biau,et al.  Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients. , 2017, European journal of cancer.

[9]  R. Kandel,et al.  A systematic review of optimal treatment strategies for localized Ewing's sarcoma of bone after neo-adjuvant chemotherapy. , 2016, Surgical oncology.

[10]  U. Dirksen,et al.  Ewing Sarcoma: Current Management and Future Approaches Through Collaboration. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  S. Lessnick,et al.  Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group , 2015, Pediatric blood & cancer.

[12]  S. Donaldson,et al.  Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children's Oncology Group , 2015, Cancer.

[13]  S. Vishnubhatla,et al.  Evaluation of outcome and prognostic factors in extraosseous Ewing sarcoma , 2014, Pediatric blood & cancer.

[14]  U. Dirksen,et al.  Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J. Healey,et al.  Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group. , 2012, Journal of Clinical Oncology.

[16]  M. Stevens,et al.  Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  A. Davidoff,et al.  Analysis of Prognostic Factors in Extraosseous Ewing Sarcoma Family of Tumors: Review of St. Jude Children’s Research Hospital Experience , 2012, Annals of Surgical Oncology.

[18]  J. Neuhaus,et al.  Clinical features and outcomes in patients with extraskeletal ewing sarcoma , 2011, Cancer.

[19]  James L. McClelland,et al.  Meta‐analysis of brain‐derived neurotrophic factor p.Val66Met in adult ADHD in four European populations , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[20]  P. Leavey,et al.  Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  R. Schmelzle,et al.  Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  O. Delattre,et al.  Extraosseous localized ewing tumors: improved outcome with anthracyclines--the French society of pediatric oncology and international society of pediatric oncology. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  H. Hense,et al.  Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  W. Winkelmann,et al.  Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  James R. Anderson,et al.  Ewing's sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J. Habrand,et al.  No benefit of ifosfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Pediatric Oncology. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  E. Gehan,et al.  Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  E. Gehan,et al.  The intergroup rhabdomyosarcoma study‐I. A final report , 1988, Cancer.

[29]  Jerad M. Gardner,et al.  Ewing sarcoma. , 2014, Seminars in diagnostic pathology.

[30]  S. Donaldson,et al.  An attempt to use a common staging system in rhabdomyosarcoma: a report of an international workshop initiated by the International Society of Pediatric Oncology (SIOP). , 1989, Medical and pediatric oncology.

[31]  H. Maurer.  The intergroup rhabdomyosarcoma study , 1982 .